AKT2 and prostate carcinoma: For example, Chen et al. investigated eight SNPs in the PTEN/AKT/mTOR axis in a case-control study that consisted of 666 prostate cancer patients and 708 cancer-free controls in a Chinese population, and they observed significant associations between prostate cancer risk and AKT2 rs7254617 variant genotypes18.